O'Neill, Barry V.
1369  results:
Search for persons X
?
 
?
6

The effects of GSK2981710, a medium‐chain triglyceride, on ..:

O'Neill, Barry V. ; Dodds, Chris M. ; Miller, Sam R....
Human Psychopharmacology: Clinical and Experimental.  34 (2019)  3 - p. , 2019
 
?
7

Effects of two doses of glucose and a caffeine–glucose comb..:

Scholey, Andrew ; Savage, Karen ; O'Neill, Barry V....
Human Psychopharmacology: Clinical and Experimental.  29 (2014)  5 - p. 434-445 , 2014
 
?
8

The potent M1 receptor allosteric agonist GSK1034702 improv..:

Nathan, Pradeep J. ; Watson, Jeannette ; Lund, Jesper...
International Journal of Neuropsychopharmacology.  16 (2013)  4 - p. 721-731 , 2013
 
?
9

Multiple‐Dose Safety, Pharmacokinetics, and Pharmacodynamic..:

Nathan, Pradeep J. ; Bush, Mark A. ; Tao, Wenli X....
The Journal of Clinical Pharmacology.  52 (2012)  10 - p. 1456-1467 , 2012
 
?
10

Opioid Receptor Modulation of Hedonic Taste Preference and ..:

Nathan, Pradeep J. ; O'Neill, Barry V. ; Bush, Mark A....
The Journal of Clinical Pharmacology.  52 (2012)  4 - p. 464-474 , 2012
 
?
12

The effects of the dopamine D3 receptor antagonist GSK59880..:

Nathan, Pradeep J. ; O'Neill, Barry V. ; Mogg, Karin...
The International Journal of Neuropsychopharmacology.  15 (2011)  2 - p. 149-161 , 2011
 
?
14

Evidence for sex differences in the loudness dependence of ..:

Oliva, Jessica L. ; Leung, Sumie ; Croft, Rodney J....
Human Psychopharmacology: Clinical and Experimental.  26 (2011)  2 - p. 172-176 , 2011
 
?
15

The loudness dependence auditory evoked potential is insens..:

Oliva, Jessica ; Leung, Sumie ; Croft, Rodney J....
Human Psychopharmacology: Clinical and Experimental.  25 (2010)  5 - p. 423-427 , 2010
 
1-15